Cargando…

Simulations of future cardiometabolic disease and life expectancy under counterfactual obesity reduction scenarios

The aim of this study was to provide decision makers with an assessment of potential future health effects of interventions against overweight and obesity (OWOB). By means of the DYNAMO-HIA tool we conducted a health impact assessment simulating future prevented disease (ischemic heart disease (IHD)...

Descripción completa

Detalles Bibliográficos
Autores principales: Bender, Anne Mette, Sørensen, Jan, Holm, Astrid, Simonsen, Kenneth, Diderichsen, Finn, Brønnum-Hansen, Henrik
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7358723/
https://www.ncbi.nlm.nih.gov/pubmed/32685361
http://dx.doi.org/10.1016/j.pmedr.2020.101150
_version_ 1783558901252227072
author Bender, Anne Mette
Sørensen, Jan
Holm, Astrid
Simonsen, Kenneth
Diderichsen, Finn
Brønnum-Hansen, Henrik
author_facet Bender, Anne Mette
Sørensen, Jan
Holm, Astrid
Simonsen, Kenneth
Diderichsen, Finn
Brønnum-Hansen, Henrik
author_sort Bender, Anne Mette
collection PubMed
description The aim of this study was to provide decision makers with an assessment of potential future health effects of interventions against overweight and obesity (OWOB). By means of the DYNAMO-HIA tool we conducted a health impact assessment simulating future prevented disease (ischemic heart disease (IHD), diabetes, stroke, and multi morbidity) incidence, prevalence and life expectancy (LE) related to a scenario where OWOB is reduced by 25% and a scenario where obesity is eliminated. The study covered projected number of persons living in Copenhagen, Denmark during year 2014–2040 (n 2040 = 742,129). Reducing the proportion of men/women with OWOB with 25% will increase population LE by 2.4/1.2 months and at the same time decrease LE with diabetes by 3.1/2.2 months. As a result of eliminating obesity, total LE will increase by 6.0/3.6 months and LE with diabetes will decrease with 9.8/10.3 months for men/women. We found no important effects on LE with IHD and stroke. This illustrates that the positive effects of lowering OWOB levels on IHD and stroke incidence is offset due to increasing total LE. Although the population of Copenhagen is relatively lean, reducing obesity levels will result in significant benefits for population cardiometabolic health status and LE. Future public health prevention programs may use the results as reference data for potential impact of reductions in OWOB.
format Online
Article
Text
id pubmed-7358723
institution National Center for Biotechnology Information
language English
publishDate 2020
record_format MEDLINE/PubMed
spelling pubmed-73587232020-07-17 Simulations of future cardiometabolic disease and life expectancy under counterfactual obesity reduction scenarios Bender, Anne Mette Sørensen, Jan Holm, Astrid Simonsen, Kenneth Diderichsen, Finn Brønnum-Hansen, Henrik Prev Med Rep Regular Article The aim of this study was to provide decision makers with an assessment of potential future health effects of interventions against overweight and obesity (OWOB). By means of the DYNAMO-HIA tool we conducted a health impact assessment simulating future prevented disease (ischemic heart disease (IHD), diabetes, stroke, and multi morbidity) incidence, prevalence and life expectancy (LE) related to a scenario where OWOB is reduced by 25% and a scenario where obesity is eliminated. The study covered projected number of persons living in Copenhagen, Denmark during year 2014–2040 (n 2040 = 742,129). Reducing the proportion of men/women with OWOB with 25% will increase population LE by 2.4/1.2 months and at the same time decrease LE with diabetes by 3.1/2.2 months. As a result of eliminating obesity, total LE will increase by 6.0/3.6 months and LE with diabetes will decrease with 9.8/10.3 months for men/women. We found no important effects on LE with IHD and stroke. This illustrates that the positive effects of lowering OWOB levels on IHD and stroke incidence is offset due to increasing total LE. Although the population of Copenhagen is relatively lean, reducing obesity levels will result in significant benefits for population cardiometabolic health status and LE. Future public health prevention programs may use the results as reference data for potential impact of reductions in OWOB. 2020-06-18 /pmc/articles/PMC7358723/ /pubmed/32685361 http://dx.doi.org/10.1016/j.pmedr.2020.101150 Text en © 2020 The Authors http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Regular Article
Bender, Anne Mette
Sørensen, Jan
Holm, Astrid
Simonsen, Kenneth
Diderichsen, Finn
Brønnum-Hansen, Henrik
Simulations of future cardiometabolic disease and life expectancy under counterfactual obesity reduction scenarios
title Simulations of future cardiometabolic disease and life expectancy under counterfactual obesity reduction scenarios
title_full Simulations of future cardiometabolic disease and life expectancy under counterfactual obesity reduction scenarios
title_fullStr Simulations of future cardiometabolic disease and life expectancy under counterfactual obesity reduction scenarios
title_full_unstemmed Simulations of future cardiometabolic disease and life expectancy under counterfactual obesity reduction scenarios
title_short Simulations of future cardiometabolic disease and life expectancy under counterfactual obesity reduction scenarios
title_sort simulations of future cardiometabolic disease and life expectancy under counterfactual obesity reduction scenarios
topic Regular Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7358723/
https://www.ncbi.nlm.nih.gov/pubmed/32685361
http://dx.doi.org/10.1016/j.pmedr.2020.101150
work_keys_str_mv AT benderannemette simulationsoffuturecardiometabolicdiseaseandlifeexpectancyundercounterfactualobesityreductionscenarios
AT sørensenjan simulationsoffuturecardiometabolicdiseaseandlifeexpectancyundercounterfactualobesityreductionscenarios
AT holmastrid simulationsoffuturecardiometabolicdiseaseandlifeexpectancyundercounterfactualobesityreductionscenarios
AT simonsenkenneth simulationsoffuturecardiometabolicdiseaseandlifeexpectancyundercounterfactualobesityreductionscenarios
AT diderichsenfinn simulationsoffuturecardiometabolicdiseaseandlifeexpectancyundercounterfactualobesityreductionscenarios
AT brønnumhansenhenrik simulationsoffuturecardiometabolicdiseaseandlifeexpectancyundercounterfactualobesityreductionscenarios